Analysis of U.S. Food and Drug Administration Draft Guidance on Clinical Trials with Psychedelic Drugs | Husch Blackwell LLP

On June 23, 2023 the U.S. Food and Drug Administration (FDA) published a draft guidance document with foundational considerations for researchers that are developing psychedelic drugs...

Related Keywords

Tiffany Farchione ,Marketing Authorization For Pharmaceuticals ,Drug Development ,Division Of Psychiatry ,Drug Evaluation ,Federal Food ,Cosmetic Act ,International Council ,Technical Requirements ,Human Use ,Nonclinical Safety Studies ,Human Clinical Trials ,Marketing Authorization ,Abuse Potential ,